Analysts have given Pacira BioSciences a total of 7 ratings, with the consensus rating being Buy. The average one-year price target is $18.0, indicating a potential 9.42% upside.
The Smithsonian’s National Zoo and Conservation Biology Institute announced the loss of Kamala, a cherished Asian elephant who served as both a beloved zoo member and an advocate for her species.